The binding of invariant chain to major histocompatibility complex (MHC) proteins is an important step in processing of MHC class II proteins and in antigen presentation. The question of how invariant chain can bind to all MHC class II proteins is central to understanding these processes. We have employed molecular modeling to predict the structure of class 11-associated invariant chain peptide (CLIP)-MHC protein complexes and to ask whether the predicted mode of association could be general across all MHC class II proteins.
Invariant chain plays an important role in the processing of major histocompatibility complex (MHC) class II proteins, by blocking binding of antigenic peptides until appropriate. To do this, it has the unique capability of binding to the products of all MHC class II alleles, apparently overcoming the extensive polymorphism that gives each protein a unique motif of antigenic peptides that it binds and presents. The question of how invariant chain blocks antigen binding (suggesting a common binding site), yet is apparently unconstrained by known antigen-binding motifs, has remained difficult to resolve, with recently reported evidence both for and against its binding like a conventional antigen, within the groove of the MHC class II molecule (1) (2) (3) (4) .
We have sought to address these questions by using computer modeling to predict a detailed structure of invariantchain peptide to MHC class II protein and to assess the properties of this hypothetical structure against available data. The unusual structural characteristics of MHC protein make it particularly suited to modeling: extensive polymorphism, within an open but tightly packed antigen binding site, framed by a highly conserved backbone fold. The striking conservation of the backbone structure of MHC proteins from allele to allele-e.g., in class I, 0.45 A C" rms between HLA-A2 and HLA-Aw68 (5)-provides an important foundation for accurate modeling of the structural differences between products of different alleles, the polymorphic side chains. The dense packing of the groove of MHC proteins tightly constrains the possible conformations of these side chains.
We have modeled the complex between the product of HLA-DR3 and the class II-associated invariant chain peptide (CLIP), an important test case for the accuracy of modeling, whose structure is being solved by x-ray crystallography. Furthermore, we have used modeling's ability to predict and compare the structures of multiple MHC alleles, to assess in detail the possibility that CLIP might be binding to all class II MHC proteins in an identical way. Our results provide several areas of new insights: (i) a detailed structural model of CLIP-MHC binding and interactions and predictions that can be used to test the model, (ii) evidence of a general mode of association of CLIP across all class II MHC proteins, and (iii) specific structural understanding of how CLIP can bind to the products of many different MHC alleles.
MATERIALS AND METHODS
Molecular Modeling. All modeling calculations were performed with self-consistent ensemble optimization (SCEO) as described (6, 7) , by using the program CARA through the LOOK interface (Molecular Applications Group). We started from the DR1-HA crystal structure (8) , Protein Data Bank code 1DLH (9) . SCEO calculations were generated by using linear cooling from 6000 K to 298 K over 15 cycles with "heavy" data collection, followed by 10 cycles of equilibration at 298 K. Structure predictions for each residue were taken from the highest probability conformation of the residue in the calculated ensemble of the final equilibration cycle. All calculation steps and parameters were as described (7); however, the jump frequency was reduced to one jump per 100 steps, and the minimum conformational sample per cycle was increased to 5000.
To build the initial model of DR3, side-chain coordinates for all polymorphic positions (9, 10, 11, 12, 13, 26, 28, 30 
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RESULTS AND DISCUSSION
We have modeled the class II MHC allele DR3 by using a completely automated procedure that predicts the coordinates of polymorphic side chains upon a fixed backbone framework, as described (7, 10, 11) . Tests of this procedure on the murine class I allele H-2Kb, starting from the structure of HLA-A2, gave a coordinate rms versus the crystal structure of 0.97 A for the polymorphic residues (C.L. and H.M.M., unpublished results) and overall showed nearly the same level of similarity to the crystal structure as the two, independently solved crystal structures of H-2Kb (12, 13) share with each other. We used the crystal structure of HLA-DR1 (8) as the starting point for the model and modeled ab initio all 20 polymorphisms between the DR1 and DR3 chains. Within the peptide-binding domain, the main focus of this study, the DR1 and DR3 18 chains share about 82% identity.
Nine of the polymorphisms seem likely to have significant effects on peptide binding within the cleft (Fig. 1A) . Several changes deepen the cleft along the interface between a and 13 chains (Trp-9 -* Glu, Leu-11 --Ser, Phe-13 --Ser), while two adjacent changes create raised areas on the cleft floor (Leu-25 --Tyr, Cys-30 --Tyr). Glu-f39 sits at the base of the P6 and P9 pockets and could favor a basic anchor residue. Gly-86 --Val reduces one side of the P1 pocket, consistent with experimental observations that this mutation modulates P1-pocket specificity (15) (16) (17) .
We have modeled CLIP within the cleft of HLA-DR3, using as a framework the backbone of the influenza virus hemagglutinin peptide cocrystallized with DR1 (8) . Several criteria guided out placement of the CLIP-81-104 peptide: (i) some experimental evidence indicates that CLIP binds within the cleft much like antigenic peptides (2-4). (ii) The N-terminal residues 81-87 do not contain an appropriate binding motif. In particular, the high proline content (>50%) seems unlikely to provide a good fit to the cleft. (iii) We sought a conformation that would place a hydrophobic residue in the P1 anchor pocket and also in the P7 and P9 pockets. We considered seven different placements, three of which met this criterion. (iv) The existence of a proline at position 96 in CLIP led us to examine which locations in the cleft could accommodate its unusual conformation requirements. Most positions within the extended conformation of the peptide in the cleft fit the proline 4) torsion reasonably well, but one of the three candidates (placing Pro-96 in the P4 position; 4) = 130°) did not. Of the remaining two candidates, one placed Pro-96 in a pocket (P6) where it fit well, while the other created strong steric clashes to the proline side chain (P9). We chose the former. (v) This alignment is consistent with CLIP alanine-scanning data on binding to DR1 and DR17 (3) . Using this alignment, we modeled all residues of CLIP within our DR3 structure. The CLIP-DR3 complex model was deposited as a blind prediction with several independent investigators in February 1995 and submitted to the upcoming Asilomar modeling evaluation conference.
The model predicts Met-91 in the deep P1 anchor pocket, Met-93 in the P3 pocket, Pro-96 in P6, Leu-97 in P7, and Met-99 in P9 (Fig. 1B) . Lys-90, Arg-92, Thr-95, and Leu-98 are predicted to point upwards into solvent. Our model indicates that CLIP can fit directly into the cleft like an antigenic peptide, without bad contacts, and predicts a variety of detailed interactions between DR3 and CLIP (Fig.  2) . Our model gives a good fit of CLIP into the DR3 peptide-binding cleft by several criteria: pattern of hydrophobic burial of peptide side chains, pattern of hydrogen bonding to the MHC protein, and absence of conformational strains or bad contacts. One strained interaction was observed, between CLIP Pro-96, and DR3 Asn-a62, which normally hydrogen bonds to the peptide amide group of the P6 peptide residue. The placement of Pro-96 at the P6 position makes this hydrogen bond impossible. It is striking that the model fills the two deeply buried anchor pockets (P1 and P9) with methionine, a rare amino acid. Methionine has the unique property of providing a large hydrophobic side chain with torsional freedom for every atom in the side chain. This unmatched flexibility may allow CLIP to satisfy the requirement for hydrophobic burial in these anchor pockets in some allelic products-e.g., Pl in DR17-and still fit to other allelic products in which these pockets are modified or reduced-e.g., by the 1386 mutation in DR3.
To investigate the hypothesis that CLIP might bind in a general way across all class II MHC proteins, we have modeled CLIP with the murine class II I-Ak, I-Au, and I-Ad, whose structures have been modeled by these methods (10) . We placed CLIP in the peptide-binding clefts of these proteins in an identical registry to that in DR3, and modeled all side chains of the peptide ab initio. This binding model fit CLIP into all three proteins (Fig. 3) P1 and P9 and the P3, P6, and P7 pockets. DR3 residues contacting CLIP in these pockets are marked by small labels. The schematic above the figure presents the pattern of hydrophobic burial (downward arrows) versus accessibility (upward arrows) for the side chains of CLIP. The figure was generated by using LOOK (Molecular Applications Group).
(Leu-316) pockets (data not shown). The I-A-CLIP complexes showed similar patterns of hydrogen bonds, contacts, and hydrophobic burial as the DR3-CLIP complex.
These I-A-CLIP models suggest detailed predictions of allele-specific effects on CLIP binding to these class II proteins which can be compared with experimental data. Among I-Ak, I-Au, and I-Ad, there are about 17 amino acid differences in areas of the cleft that could affect peptide binding. Mapping allele-specific polymorphisms-i.e., residues where one allele differs from the amino acid shared by the other two alleles-to the molecular surfaces of these complexes (Fig. 3) predicts interactions with individual CLIP side chains that should be detected by CLIP alanine-scanning mutagenesis experiments (1) . By scrutinizing such data for allele-specific effects-i.e., a CLIP mutation that affects binding to two of the alleles identically, but differently to the third-interactions between individual allele-specific polymorphic residues in MHC proteins and individual residues in CLIP can be identified.
Trp-,B61 (DR numbering, which will be used throughout this paper) is a highly conserved residue across both class II and class I MHC proteins, one of five residues forming the P7 pocket in DR1 (8) . I-AU contains an unusual polymorphism in which Trp-,861 is mutated to a Tyr, shifting the wall of the P7 pocket in our model (10) and possibly favoring a smaller P7 side chain. This result is supported by experimental data on the effects on mutating CLIP residues to alanine, which were measured by changes in the ability of CLIP to compete with standard peptides for binding to I-Ak, I-Au, and I-Ad (1) .
Just 4 of the 18 positions in CLIP that were tested showed strong allele-specific binding effects: Met-91, Met-93, Pro-96, *+, <20% increase; + +, <50% increase; +++ >80% increase; 0, no effect; -, <20% decrease; ---, >80% decrease.
and Leu-97. In I-Ak, mutating CLIP Leu-97 -+ Ala appears to cause a slight decrease in binding, whereas in I-Au, it actually improves binding substantially. Moreover, this mutation has the same effect in I-Ad as in I-Ak, indicating that a U-specific polymorphism is involved. Trp-j361 is one of the few locations interacting with peptide that has a U-specific polymorphism (Fig. 3A) . The only other polymorphism among the P7 contact residues is the D-specific mutation Ile-,B28 -> Thr. However, this side chain is substantially shorter than in DR1 (Glu), and, from its location deep on the floor of the 13 sheet, is less likely to have interactions that can distinguish the P7 side chain (see Fig. 3C ).
There is only one K-specific polymorphism that appears Experimentally, mutating CLIP Met-99 --Ala causes a roughly equivalent improvement in binding to all three proteins. Table 1 summarizes these results and predictions. Broadly interpreted, they suggest that CLIP not only can bind within the cleft of the MHC protein in the same manner as an antigenic peptide but also that it binds in an identical way to products of various class II alleles, at least for the human DRs and murine I-As. We have identified structural characteristics of CLIP which in our models appear to be important for binding the products of multiple alleles (Table 2 ). These features are not proposed to be optimal for binding to any given protein, but rather to permit CLIP to fit all allelic products. Further experiments can directly test our predictions. Mutants of I-Ak and I-AU have recently been constructed which switch residues 139, 1338, and 1361 to the amino acid of the opposite allele, in the contexts of both I-Ak and I-Au (10). Our models predict that these polymorphisms modulate the specificity of class II interactions with CLIP residues 96 and 97, respectively, and possibly 99 (Table 1) . By assaying binding of the appropriate alanine-substituted CLIP peptides on these mutants, the predicted CLIP-MHC protein interactions can be specifically tested.
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